APO Research, Inc.

Global Biological Sample Cryopreservation Market Outlook and Growth Opportunities 2026

Choose your research edition.

Compare the research focus and single-user price for each edition.
Research editionIndustry ResearchIndustry Growth & TrendsMarket StructureMarket Outlook & Growth OpportunitiesSelectedMarket Analysis & Forecast
Core differenceUnderstand the overall industry landscape, competition and leading companies.Examine growth drivers and how demand is developing across regional markets.Compare how the market is divided across companies, types and applications.Compare regional and country-level demand to assess geographic market opportunities.Assess market size, historical trends and forecasts for forward planning.
Single-user price$2,950 USD$3,450 USD$3,950 USD$4,250 USD$4,950 USD
Your choiceView editionView editionView editionCurrent editionView edition
View pricing & licenses

Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.

Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.

Product & engineering

Understand the product.

Biological Sample Cryopreservation encompasses the controlled freezing, vitrification, and cryogenic storage technologies used to preserve living cells, tissues, reproductive materials, microorganisms, and temperature sensitive biological specimens for subsequent recovery, analysis, or biological use. The underlying preservation mechanism involves reducing molecular mobility, enzymatic activity, and biochemical degradation at ultralow temperatures while limiting structural and functional damage associated with ice crystallization, osmotic imbalance, solute concentration, and membrane disruption. Conventional slow freezing applies controlled cooling rates to promote extracellular ice formation and cellular dehydration while reducing intracellular ice formation. Vitrification uses higher cryoprotectant concentrations and rapid temperature transitions to produce an amorphous solid state with minimal ice crystallization. Cryoprotective formulations incorporate permeating agents such as dimethyl sulfoxide, glycerol, and ethylene glycol, together with nonpermeating sugars, buffering systems, and other formulation components selected according to sample characteristics and freezing methods. Preservation performance depends on the interaction between cooling rate, cryoprotectant composition, sample volume, thermal history, storage temperature, and subsequent warming conditions.

Commercial cryopreservation technologies include programmable controlled rate freezers, mechanical ultralow temperature and cryogenic freezers, liquid nitrogen storage systems, automated cryogenic sample repositories, and specialized cryopreservation media. Equipment configurations incorporate cascade refrigeration circuits, liquid nitrogen cooling and distribution assemblies, vacuum insulated stainless steel vessels, thermal control systems, and automated sample handling mechanisms. Mechanical freezers operating near minus 80°C accommodate biological materials with compatible storage requirements, while systems operating near minus 150°C and liquid nitrogen environments approaching minus 196°C are used for extended preservation of viable cellular specimens. Cryogenic storage may employ liquid phase or nitrogen vapor phase configurations, with storage architecture determined by sample characteristics, thermal stability requirements, and contamination considerations. Commercial applications encompass biological sample repositories, biomedical research, biopharmaceutical cell banking and manufacturing, cell and gene therapy, assisted reproduction, clinical specimen preservation, and animal breeding. The product market covers dedicated freezing and cryogenic storage equipment and formulated cryopreservation media used directly in biological preservation. Independent storage and logistics services, general laboratory refrigeration, standalone sample packaging consumables, and unrelated laboratory equipment fall outside the product revenue boundary.

Selected research

Market Outlook & Growth Opportunities

Global Biological Sample Cryopreservation Market Outlook and Growth Opportunities 2026

MARKET AT A GLANCE

Scale & outlook

2024
≈ 860USD million
2032
3,057.45USD million
Market size · USD million
02,0004,0002024 · Approx. 860 USD million≈ 86020242025 · Approx. 1,812.4 USD million≈ 1,812.420252026 · 1,933.15 USD million1,933.1520262032 · 3,057.45 USD million3,057.452032

Select a bar to inspect its value.

Source: APO Research, Inc.

Market perspective

According to APO Research, Inc, the global Biological Sample Cryopreservation market was valued at approximately USD 1,812.4 million in 2025 and is projected to reach USD 1,933.15 million in 2026 and USD 3,057.45 million by 2032, representing a compound annual growth rate (CAGR) of 7.94% from 2026 to 2032. Market revenue comprises dedicated controlled rate freezing equipment, ultralow temperature and cryogenic storage systems, automated biological sample repositories, and commercial cryopreservation media. Growth is driven by expanding biological specimen inventories, increased production of cell based therapeutics, and replacement of aging laboratory storage equipment. Equipment revenue depends on new installations, replacement cycles, and average selling prices, while cryopreservation media consumption follows the number of biological samples and cell manufacturing batches processed. Automated liquid nitrogen storage systems increase equipment expenditure per installation where sample capacity, retrieval frequency, and handling requirements justify additional capital investment.

Ultralow temperature freezers represent an established component of biological sample storage infrastructure. PHC Group estimated the global ultralow temperature freezer market at approximately USD 860 million in 2024 and identified emerging replacement demand for energy efficient equipment among pharmaceutical manufacturers and contract development and manufacturing organizations. Research institutions and biobanks face similar requirements as existing freezer fleets age and electricity consumption becomes a larger component of operating expenditure. In China, Haier Biomedical manufactures ultralow temperature storage equipment in Qingdao and intelligent liquid nitrogen storage systems in Chengdu, providing domestic manufacturing capacity across conventional and cryogenic storage technologies. Equipment demand in China and other Asian markets is influenced by biological sample repository development, pharmaceutical manufacturing investment, and the adoption of automated storage systems. North America, Europe, and Japan additionally generate replacement demand from established laboratory and biopharmaceutical infrastructure. Conventional freezer pricing remains subject to manufacturer competition, while automated cryogenic installations carry higher equipment values associated with insulated storage vessels, robotic handling, monitoring, and temperature management systems.

Cryogenic storage equipment and specialized preservation media are also influenced by the commercialization of advanced therapies and reproductive technologies. Cryoport reported USD 79.68 million in Life Sciences Products revenue in 2025, an increase of 6.6%, with stronger product demand in Europe, the Middle East, Africa, and Asia Pacific, alongside animal health applications in the Americas. Its product revenue includes cryogenic storage and transport equipment, reflecting demand from biological repositories, reproductive material preservation, and commercial cell therapy supply chains. BioLife Solutions reported USD 96.2 million in 2025 revenue, with biopreservation media accounting for approximately 87% of its business, including cryogenic freezing and hypothermic preservation formulations. Repligen completed its acquisition of BioLife Solutions in October 2026, adding the CryoStor cryopreservation media family to its bioprocessing business. As cell therapies advance from clinical development into commercial manufacturing, repeated production batches and frozen cellular inventories increase consumption of qualified freezing formulations. Cryoprotectant composition, post thaw cell recovery, and manufacturing process compatibility influence product selection and limit rapid substitution of established formulations. The market outlook consequently reflects continued equipment installations and replacements, a rising contribution from automated cryogenic storage, and recurring preservation media purchases tied to biological manufacturing activity.

Full market overview

This report provides an overview of the global Biological Sample Cryopreservation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biological Sample Cryopreservation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biological Sample Cryopreservation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biological Sample Cryopreservation market.

Biological Sample Cryopreservation Segment by Company

  • Thermo Fisher Scientific
  • Haier Biomedical
  • PHCbi
  • Repligen
  • Cryoport
  • Azenta Life Sciences
  • Cytiva
  • Sartorius
  • FUJIFILM Biosciences
  • Lonza
  • Corning
  • Eppendorf
  • Greiner
  • SARSTEDT
  • Terumo
  • CooperSurgical
  • Vitrolife
  • Nexpring Health
  • Macopharma
  • Miltenyi Biotec
  • STEMCELL Technologies
  • Kitazato
  • Zhongke Meiling Cryogenics
  • AUCMA
  • BIOBASE
  • Genepoint Technologies
  • Origincell Biological Cryo Equipment
  • Basecare Medical
  • Hamilton Company
  • LiCONiC
  • ASKION
  • SPT Labtech
  • B Medical Systems
  • Custom Biogenic Systems
  • IC Biomedical
  • Cryo Bio System
  • Stirling Ultracold
  • Helmer Scientific
  • Micronic
  • OriGen Biomedical
  • BINDER
  • Liebherr
  • Esco Lifesciences
  • Cryopal
  • Cryotherm
  • Cryo Diffusion
  • Statebourne Cryogenics
  • Celltrio
  • ThermoGenesis
  • Jiangsu SERLNG
  • SYLAB
  • Consarctic
  • PromoCell
  • FertiPro
  • CryoLogic
  • Cryofab

Biological Sample Cryopreservation Segment by Type

  • Cryopreservation Equipment
  • Cryopreservation Media & Reagents
  • Cryopreservation Containers & Accessories
  • Cryopreservation Services

Biological Sample Cryopreservation Segment by Application

  • Biobanking
  • Biomedical Research
  • Biopharmaceutical Manufacturing
  • Cell & Gene Therapy
  • Assisted Reproduction
  • Clinical Diagnostics
  • Animal Breeding

Biological Sample Cryopreservation Segment by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Poland
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Southeast Asia
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Türkiye
    • GCC Countries

Study Objectives

  1. To analyze and research the global Biological Sample Cryopreservation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
  2. To present the Biological Sample Cryopreservation key companies, revenue, market share, and recent developments.
  3. To split the Biological Sample Cryopreservation breakdown data by regions, type, companies, and application.
  4. To analyze the global and key regions Biological Sample Cryopreservation market potential and advantage, opportunity and challenge, restraints, and risks.
  5. To identify Biological Sample Cryopreservation significant trends, drivers, influence factors in global and regions.
  6. To analyze Biological Sample Cryopreservation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

  1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Sample Cryopreservation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  2. This report will help stakeholders to understand the global industry status and trends of Biological Sample Cryopreservation and provides them with information on key market drivers, restraints, challenges, and opportunities.
  3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
  4. This report stays updated with novel technology integration, features, and the latest developments in the market.
  5. This report helps stakeholders to gain insights into which regions to target globally.
  6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Sample Cryopreservation.
  7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

  1. Chapter 1: Introduces the report scope of the report, global total market size.
  2. Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biological Sample Cryopreservation industry.
  3. Chapter 3: Detailed analysis of Biological Sample Cryopreservation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  4. Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  5. Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  6. Chapter 6: Sales value of Biological Sample Cryopreservation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
  7. Chapter 7: Sales value of Biological Sample Cryopreservation in country level. It provides sigmate data by Type, and by Application for each country/region.
  8. Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
  9. Chapter 9: Concluding Insights.

More report detail

Tables and figures

List of Tables

  • Table 1. Biological Sample Cryopreservation Industry Trends
  • Table 2. Biological Sample Cryopreservation Industry Drivers
  • Table 3. Biological Sample Cryopreservation Industry Opportunities and Challenges
  • Table 4. Biological Sample Cryopreservation Industry Restraints
  • Table 5. Global Biological Sample Cryopreservation Revenue by Company (US$ Million) & (2021-2026)
  • Table 6. Global Biological Sample Cryopreservation Revenue Share by Company (2021-2026)
  • Table 7. Global Biological Sample Cryopreservation Company Ranking, (2024-2026) & (US$ Million)
  • Table 8. Global Biological Sample Cryopreservation Key Company Manufacturing Base & Headquarters
  • Table 9. Global Biological Sample Cryopreservation Company, Product Type & Application
  • Table 10. Global Biological Sample Cryopreservation Company Establishment Date
  • Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
  • Table 12. Global Biological Sample Cryopreservation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
  • Table 13. Mergers & Acquisitions, Expansion
  • Table 14. Significant Companies of Cryopreservation Equipment
  • Table 15. Significant Companies of Cryopreservation Media & Reagents
  • Table 16. Significant Companies of Cryopreservation Containers & Accessories
  • Table 17. Significant Companies of Cryopreservation Services
  • Table 18. Global Biological Sample Cryopreservation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
  • Table 19. Global Biological Sample Cryopreservation Sales Value by Type (2021-2026) & (US$ Million)
  • Table 20. Global Biological Sample Cryopreservation Sales Value by Type (2027-2032) & (US$ Million)
  • Table 21. Global Biological Sample Cryopreservation Sales Value Share by Type (2021-2026)
  • Table 22. Global Biological Sample Cryopreservation Sales Value Share by Type (2027-2032)
  • Table 23. Significant Companies of Biobanking
  • Table 24. Significant Companies of Biomedical Research
  • Table 25. Significant Companies of Biopharmaceutical Manufacturing
  • Table 26. Significant Companies of Cell & Gene Therapy
  • Table 27. Significant Companies of Assisted Reproduction
  • Table 28. Significant Companies of Clinical Diagnostics
  • Table 29. Significant Companies of Animal Breeding
  • Table 30. Global Biological Sample Cryopreservation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
  • Table 31. Global Biological Sample Cryopreservation Sales Value by Application (2021-2026) & (US$ Million)
  • Table 32. Global Biological Sample Cryopreservation Sales Value by Application (2027-2032) & (US$ Million)
  • Table 33. Global Biological Sample Cryopreservation Sales Value Share by Application (2021-2026)
  • Table 34. Global Biological Sample Cryopreservation Sales Value Share by Application (2027-2032)
  • Table 35. Global Biological Sample Cryopreservation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 36. Global Biological Sample Cryopreservation Sales Value by Region (2021-2026) & (US$ Million)
  • Table 37. Global Biological Sample Cryopreservation Sales Value Share by Region (2021-2026)
  • Table 38. Global Biological Sample Cryopreservation Sales Value by Region (2027-2032) & (US$ Million)
  • Table 39. Global Biological Sample Cryopreservation Sales Value Share by Region (2027-2032)
  • Table 40. Global Biological Sample Cryopreservation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 41. Global Biological Sample Cryopreservation Sales Value by Country (2021-2026) & (US$ Million)
  • Table 42. Global Biological Sample Cryopreservation Sales Value Market Share by Country (2021-2026)
  • Table 43. Global Biological Sample Cryopreservation Sales Value by Country (2027-2032) & (US$ Million)
  • Table 44. Global Biological Sample Cryopreservation Sales Value Market Share by Country (2027-2032)
  • Table 45. Thermo Fisher Scientific Company Information
  • Table 46. Thermo Fisher Scientific Business Overview
  • Table 47. Thermo Fisher Scientific Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 48. Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
  • Table 49. Thermo Fisher Scientific Recent Development
  • Table 50. Haier Biomedical Company Information
  • Table 51. Haier Biomedical Business Overview
  • Table 52. Haier Biomedical Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 53. Haier Biomedical Biological Sample Cryopreservation Product Portfolio
  • Table 54. Haier Biomedical Recent Development
  • Table 55. PHCbi Company Information
  • Table 56. PHCbi Business Overview
  • Table 57. PHCbi Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 58. PHCbi Biological Sample Cryopreservation Product Portfolio
  • Table 59. PHCbi Recent Development
  • Table 60. Repligen Company Information
  • Table 61. Repligen Business Overview
  • Table 62. Repligen Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 63. Repligen Biological Sample Cryopreservation Product Portfolio
  • Table 64. Repligen Recent Development
  • Table 65. Cryoport Company Information
  • Table 66. Cryoport Business Overview
  • Table 67. Cryoport Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 68. Cryoport Biological Sample Cryopreservation Product Portfolio
  • Table 69. Cryoport Recent Development
  • Table 70. Azenta Life Sciences Company Information
  • Table 71. Azenta Life Sciences Business Overview
  • Table 72. Azenta Life Sciences Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 73. Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
  • Table 74. Azenta Life Sciences Recent Development
  • Table 75. Cytiva Company Information
  • Table 76. Cytiva Business Overview
  • Table 77. Cytiva Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 78. Cytiva Biological Sample Cryopreservation Product Portfolio
  • Table 79. Cytiva Recent Development
  • Table 80. Sartorius Company Information
  • Table 81. Sartorius Business Overview
  • Table 82. Sartorius Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 83. Sartorius Biological Sample Cryopreservation Product Portfolio
  • Table 84. Sartorius Recent Development
  • Table 85. FUJIFILM Biosciences Company Information
  • Table 86. FUJIFILM Biosciences Business Overview
  • Table 87. FUJIFILM Biosciences Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 88. FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
  • Table 89. FUJIFILM Biosciences Recent Development
  • Table 90. Lonza Company Information
  • Table 91. Lonza Business Overview
  • Table 92. Lonza Biological Sample Cryopreservation Revenue (US$ Million) and Gross Margin (2021-2026)
  • Table 93. Lonza Biological Sample Cryopreservation Product Portfolio
  • Table 94. Lonza Recent Development
  • Table 95. Corning Company Information
  • Table 96. Corning Business Overview
  • Table 97. Corning Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 98. Corning Biological Sample Cryopreservation Product Portfolio
  • Table 99. Corning Recent Development
  • Table 100. Eppendorf Company Information
  • Table 101. Eppendorf Business Overview
  • Table 102. Eppendorf Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 103. Eppendorf Biological Sample Cryopreservation Product Portfolio
  • Table 104. Eppendorf Recent Development
  • Table 105. Greiner Company Information
  • Table 106. Greiner Business Overview
  • Table 107. Greiner Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 108. Greiner Biological Sample Cryopreservation Product Portfolio
  • Table 109. Greiner Recent Development
  • Table 110. SARSTEDT Company Information
  • Table 111. SARSTEDT Business Overview
  • Table 112. SARSTEDT Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 113. SARSTEDT Biological Sample Cryopreservation Product Portfolio
  • Table 114. SARSTEDT Recent Development
  • Table 115. Terumo Company Information
  • Table 116. Terumo Business Overview
  • Table 117. Terumo Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 118. Terumo Biological Sample Cryopreservation Product Portfolio
  • Table 119. Terumo Recent Development
  • Table 120. CooperSurgical Company Information
  • Table 121. CooperSurgical Business Overview
  • Table 122. CooperSurgical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 123. CooperSurgical Biological Sample Cryopreservation Product Portfolio
  • Table 124. CooperSurgical Recent Development
  • Table 125. Vitrolife Company Information
  • Table 126. Vitrolife Business Overview
  • Table 127. Vitrolife Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 128. Vitrolife Biological Sample Cryopreservation Product Portfolio
  • Table 129. Vitrolife Recent Development
  • Table 130. Nexpring Health Company Information
  • Table 131. Nexpring Health Business Overview
  • Table 132. Nexpring Health Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 133. Nexpring Health Biological Sample Cryopreservation Product Portfolio
  • Table 134. Nexpring Health Recent Development
  • Table 135. Macopharma Company Information
  • Table 136. Macopharma Business Overview
  • Table 137. Macopharma Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 138. Macopharma Biological Sample Cryopreservation Product Portfolio
  • Table 139. Macopharma Recent Development
  • Table 140. Miltenyi Biotec Company Information
  • Table 141. Miltenyi Biotec Business Overview
  • Table 142. Miltenyi Biotec Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 143. Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
  • Table 144. Miltenyi Biotec Recent Development
  • Table 145. STEMCELL Technologies Company Information
  • Table 146. STEMCELL Technologies Business Overview
  • Table 147. STEMCELL Technologies Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 148. STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
  • Table 149. STEMCELL Technologies Recent Development
  • Table 150. Kitazato Company Information
  • Table 151. Kitazato Business Overview
  • Table 152. Kitazato Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 153. Kitazato Biological Sample Cryopreservation Product Portfolio
  • Table 154. Kitazato Recent Development
  • Table 155. Zhongke Meiling Cryogenics Company Information
  • Table 156. Zhongke Meiling Cryogenics Business Overview
  • Table 157. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 158. Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
  • Table 159. Zhongke Meiling Cryogenics Recent Development
  • Table 160. AUCMA Company Information
  • Table 161. AUCMA Business Overview
  • Table 162. AUCMA Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 163. AUCMA Biological Sample Cryopreservation Product Portfolio
  • Table 164. AUCMA Recent Development
  • Table 165. BIOBASE Company Information
  • Table 166. BIOBASE Business Overview
  • Table 167. BIOBASE Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 168. BIOBASE Biological Sample Cryopreservation Product Portfolio
  • Table 169. BIOBASE Recent Development
  • Table 170. Genepoint Technologies Company Information
  • Table 171. Genepoint Technologies Business Overview
  • Table 172. Genepoint Technologies Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 173. Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
  • Table 174. Genepoint Technologies Recent Development
  • Table 175. Origincell Biological Cryo Equipment Company Information
  • Table 176. Origincell Biological Cryo Equipment Business Overview
  • Table 177. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 178. Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
  • Table 179. Origincell Biological Cryo Equipment Recent Development
  • Table 180. Basecare Medical Company Information
  • Table 181. Basecare Medical Business Overview
  • Table 182. Basecare Medical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 183. Basecare Medical Biological Sample Cryopreservation Product Portfolio
  • Table 184. Basecare Medical Recent Development
  • Table 185. Hamilton Company Company Information
  • Table 186. Hamilton Company Business Overview
  • Table 187. Hamilton Company Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 188. Hamilton Company Biological Sample Cryopreservation Product Portfolio
  • Table 189. Hamilton Company Recent Development
  • Table 190. LiCONiC Company Information
  • Table 191. LiCONiC Business Overview
  • Table 192. LiCONiC Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 193. LiCONiC Biological Sample Cryopreservation Product Portfolio
  • Table 194. LiCONiC Recent Development
  • Table 195. ASKION Company Information
  • Table 196. ASKION Business Overview
  • Table 197. ASKION Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 198. ASKION Biological Sample Cryopreservation Product Portfolio
  • Table 199. ASKION Recent Development
  • Table 200. SPT Labtech Company Information
  • Table 201. SPT Labtech Business Overview
  • Table 202. SPT Labtech Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 203. SPT Labtech Biological Sample Cryopreservation Product Portfolio
  • Table 204. SPT Labtech Recent Development
  • Table 205. B Medical Systems Company Information
  • Table 206. B Medical Systems Business Overview
  • Table 207. B Medical Systems Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 208. B Medical Systems Biological Sample Cryopreservation Product Portfolio
  • Table 209. B Medical Systems Recent Development
  • Table 210. Custom Biogenic Systems Company Information
  • Table 211. Custom Biogenic Systems Business Overview
  • Table 212. Custom Biogenic Systems Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 213. Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
  • Table 214. Custom Biogenic Systems Recent Development
  • Table 215. IC Biomedical Company Information
  • Table 216. IC Biomedical Business Overview
  • Table 217. IC Biomedical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 218. IC Biomedical Biological Sample Cryopreservation Product Portfolio
  • Table 219. IC Biomedical Recent Development
  • Table 220. Cryo Bio System Company Information
  • Table 221. Cryo Bio System Business Overview
  • Table 222. Cryo Bio System Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 223. Cryo Bio System Biological Sample Cryopreservation Product Portfolio
  • Table 224. Cryo Bio System Recent Development
  • Table 225. Stirling Ultracold Company Information
  • Table 226. Stirling Ultracold Business Overview
  • Table 227. Stirling Ultracold Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 228. Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
  • Table 229. Stirling Ultracold Recent Development
  • Table 230. Helmer Scientific Company Information
  • Table 231. Helmer Scientific Business Overview
  • Table 232. Helmer Scientific Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 233. Helmer Scientific Biological Sample Cryopreservation Product Portfolio
  • Table 234. Helmer Scientific Recent Development
  • Table 235. Micronic Company Information
  • Table 236. Micronic Business Overview
  • Table 237. Micronic Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 238. Micronic Biological Sample Cryopreservation Product Portfolio
  • Table 239. Micronic Recent Development
  • Table 240. OriGen Biomedical Company Information
  • Table 241. OriGen Biomedical Business Overview
  • Table 242. OriGen Biomedical Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 243. OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
  • Table 244. OriGen Biomedical Recent Development
  • Table 245. BINDER Company Information
  • Table 246. BINDER Business Overview
  • Table 247. BINDER Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 248. BINDER Biological Sample Cryopreservation Product Portfolio
  • Table 249. BINDER Recent Development
  • Table 250. Liebherr Company Information
  • Table 251. Liebherr Business Overview
  • Table 252. Liebherr Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 253. Liebherr Biological Sample Cryopreservation Product Portfolio
  • Table 254. Liebherr Recent Development
  • Table 255. Esco Lifesciences Company Information
  • Table 256. Esco Lifesciences Business Overview
  • Table 257. Esco Lifesciences Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 258. Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
  • Table 259. Esco Lifesciences Recent Development
  • Table 260. Cryopal Company Information
  • Table 261. Cryopal Business Overview
  • Table 262. Cryopal Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 263. Cryopal Biological Sample Cryopreservation Product Portfolio
  • Table 264. Cryopal Recent Development
  • Table 265. Cryotherm Company Information
  • Table 266. Cryotherm Business Overview
  • Table 267. Cryotherm Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 268. Cryotherm Biological Sample Cryopreservation Product Portfolio
  • Table 269. Cryotherm Recent Development
  • Table 270. Cryo Diffusion Company Information
  • Table 271. Cryo Diffusion Business Overview
  • Table 272. Cryo Diffusion Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 273. Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
  • Table 274. Cryo Diffusion Recent Development
  • Table 275. Statebourne Cryogenics Company Information
  • Table 276. Statebourne Cryogenics Business Overview
  • Table 277. Statebourne Cryogenics Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 278. Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
  • Table 279. Statebourne Cryogenics Recent Development
  • Table 280. Celltrio Company Information
  • Table 281. Celltrio Business Overview
  • Table 282. Celltrio Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 283. Celltrio Biological Sample Cryopreservation Product Portfolio
  • Table 284. Celltrio Recent Development
  • Table 285. ThermoGenesis Company Information
  • Table 286. ThermoGenesis Business Overview
  • Table 287. ThermoGenesis Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 288. ThermoGenesis Biological Sample Cryopreservation Product Portfolio
  • Table 289. ThermoGenesis Recent Development
  • Table 290. Jiangsu SERLNG Company Information
  • Table 291. Jiangsu SERLNG Business Overview
  • Table 292. Jiangsu SERLNG Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 293. Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
  • Table 294. Jiangsu SERLNG Recent Development
  • Table 295. SYLAB Company Information
  • Table 296. SYLAB Business Overview
  • Table 297. SYLAB Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 298. SYLAB Biological Sample Cryopreservation Product Portfolio
  • Table 299. SYLAB Recent Development
  • Table 300. Consarctic Company Information
  • Table 301. Consarctic Business Overview
  • Table 302. Consarctic Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 303. Consarctic Biological Sample Cryopreservation Product Portfolio
  • Table 304. Consarctic Recent Development
  • Table 305. PromoCell Company Information
  • Table 306. PromoCell Business Overview
  • Table 307. PromoCell Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 308. PromoCell Biological Sample Cryopreservation Product Portfolio
  • Table 309. PromoCell Recent Development
  • Table 310. FertiPro Company Information
  • Table 311. FertiPro Business Overview
  • Table 312. FertiPro Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 313. FertiPro Biological Sample Cryopreservation Product Portfolio
  • Table 314. FertiPro Recent Development
  • Table 315. CryoLogic Company Information
  • Table 316. CryoLogic Business Overview
  • Table 317. CryoLogic Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 318. CryoLogic Biological Sample Cryopreservation Product Portfolio
  • Table 319. CryoLogic Recent Development
  • Table 320. Cryofab Company Information
  • Table 321. Cryofab Business Overview
  • Table 322. Cryofab Biological Sample Cryopreservation Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
  • Table 323. Cryofab Biological Sample Cryopreservation Product Portfolio
  • Table 324. Cryofab Recent Development
  • Table 325. Research Programs/Design for This Report
  • Table 326. Authors List of This Report
  • Table 327. Secondary Sources
  • Table 328. Primary Sources

List of Figures

  • Figure 1. Biological Sample Cryopreservation Product Image
  • Figure 2. Global Biological Sample Cryopreservation Market Size (US$ Million), 2021 VS 2025 VS 2032
  • Figure 3. Global Biological Sample Cryopreservation Market Size (2021-2032) & (US$ Million)
  • Figure 4. Global Biological Sample Cryopreservation Company Revenue Ranking in 2025 (US$ Million)
  • Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
  • Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
  • Figure 7. Cryopreservation Equipment Image
  • Figure 8. Cryopreservation Media & Reagents Image
  • Figure 9. Cryopreservation Containers & Accessories Image
  • Figure 10. Cryopreservation Services Image
  • Figure 11. Global Biological Sample Cryopreservation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
  • Figure 12. Global Biological Sample Cryopreservation Sales Value Share 2021 VS 2025 VS 2032
  • Figure 13. Global Biological Sample Cryopreservation Sales Value Share by Type (2021-2032)
  • Figure 14. Biobanking Image
  • Figure 15. Biomedical Research Image
  • Figure 16. Biopharmaceutical Manufacturing Image
  • Figure 17. Cell & Gene Therapy Image
  • Figure 18. Assisted Reproduction Image
  • Figure 19. Clinical Diagnostics Image
  • Figure 20. Animal Breeding Image
  • Figure 21. Global Biological Sample Cryopreservation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
  • Figure 22. Global Biological Sample Cryopreservation Sales Value Share 2021 VS 2025 VS 2032
  • Figure 23. Global Biological Sample Cryopreservation Sales Value Share by Application (2021-2032)
  • Figure 24. Global Biological Sample Cryopreservation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
  • Figure 25. Global Biological Sample Cryopreservation Sales Value Share by Region: 2021 VS 2025 VS 2032
  • Figure 26. North America Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
  • Figure 27. North America Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
  • Figure 28. Europe Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
  • Figure 29. Europe Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
  • Figure 30. Asia-Pacific Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
  • Figure 31. Asia-Pacific Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
  • Figure 32. South America Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
  • Figure 33. South America Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
  • Figure 34. Middle East & Africa Biological Sample Cryopreservation Sales Value (2021-2032) & (US$ Million)
  • Figure 35. Middle East & Africa Biological Sample Cryopreservation Sales Value Share by Country (%), 2025 VS 2032
  • Figure 36. USA Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 37. USA Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 38. USA Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 39. Canada Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 40. Canada Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 41. Canada Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 42. Mexico Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 43. Mexico Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 44. Mexico Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 45. Germany Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 46. Germany Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 47. Germany Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 48. France Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 49. France Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 50. France Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 51. U.K. Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 52. U.K. Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 53. U.K. Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 54. Italy Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 55. Italy Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 56. Italy Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 57. Spain Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 58. Spain Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 59. Spain Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 60. Russia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 61. Russia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 62. Russia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 63. Netherlands Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 64. Netherlands Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 65. Netherlands Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 66. Nordic Countries Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 67. Nordic Countries Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 68. Nordic Countries Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 69. China Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 70. China Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 71. China Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 72. Japan Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 73. Japan Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 74. Japan Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 75. South Korea Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 76. South Korea Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 77. South Korea Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 78. India Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 79. India Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 80. India Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 81. Australia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 82. Australia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 83. Australia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 84. Southeast Asia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 85. Southeast Asia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 86. Southeast Asia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 87. Brazil Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 88. Brazil Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 89. Brazil Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 90. Argentina Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 91. Argentina Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 92. Argentina Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 93. Chile Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 94. Chile Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 95. Chile Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 96. Colombia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 97. Colombia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 98. Colombia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 99. Peru Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 100. Peru Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 101. Peru Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 102. Saudi Arabia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 103. Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 104. Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 105. Israel Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 106. Israel Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 107. Israel Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 108. UAE Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 109. UAE Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 110. UAE Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 111. Turkey Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 112. Turkey Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 113. Turkey Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 114. Iran Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 115. Iran Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 116. Iran Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 117. Egypt Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032) & (US$ Million)
  • Figure 118. Egypt Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032 & (%)
  • Figure 119. Egypt Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032 & (%)
  • Figure 120. Years Considered
  • Figure 121. Research Process
  • Figure 122. Key Executives Interviewed

Scope & coverage.

By Type
  • Cryopreservation Equipment
  • Cryopreservation Media & Reagents
  • Cryopreservation Containers & Accessories
  • Cryopreservation Services
By Application
  • Biobanking
  • Biomedical Research
  • Biopharmaceutical Manufacturing
  • Cell & Gene Therapy
  • Assisted Reproduction
  • Clinical Diagnostics
  • Animal Breeding
Companies covered
  • Thermo Fisher Scientific
  • Haier Biomedical
  • PHCbi
  • Repligen
  • Cryoport
  • Azenta Life Sciences
  • Cytiva
  • Sartorius
  • FUJIFILM Biosciences
  • Lonza
  • Corning
  • Eppendorf
  • Greiner
  • SARSTEDT
  • Terumo
  • CooperSurgical
  • Vitrolife
  • Nexpring Health
  • Macopharma
  • Miltenyi Biotec
  • STEMCELL Technologies
  • Kitazato
  • Zhongke Meiling Cryogenics
  • AUCMA
  • BIOBASE
  • Genepoint Technologies
  • Origincell Biological Cryo Equipment
  • Basecare Medical
  • Hamilton Company
  • LiCONiC
  • ASKION
  • SPT Labtech
  • B Medical Systems
  • Custom Biogenic Systems
  • IC Biomedical
  • Cryo Bio System
  • Stirling Ultracold
  • Helmer Scientific
  • Micronic
  • OriGen Biomedical
  • BINDER
  • Liebherr
  • Esco Lifesciences
  • Cryopal
  • Cryotherm
  • Cryo Diffusion
  • Statebourne Cryogenics
  • Celltrio
  • ThermoGenesis
  • Jiangsu SERLNG
  • SYLAB
  • Consarctic
  • PromoCell
  • FertiPro
  • CryoLogic
  • Cryofab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biological Sample Cryopreservation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biological Sample Cryopreservation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biological Sample Cryopreservation Market Dynamics
  1. 2.1 Biological Sample Cryopreservation Industry Trends
  2. 2.2 Biological Sample Cryopreservation Industry Drivers
  3. 2.3 Biological Sample Cryopreservation Industry Opportunities and Challenges
  4. 2.4 Biological Sample Cryopreservation Industry Restraints
3 Biological Sample Cryopreservation Market by Company
  1. 3.1 Global Biological Sample Cryopreservation Company Revenue Ranking in 2025
  2. 3.2 Global Biological Sample Cryopreservation Revenue by Company (2021-2026)
  3. 3.3 Global Biological Sample Cryopreservation Company Ranking (2024-2026)
  4. 3.4 Global Biological Sample Cryopreservation Company Manufacturing Base and Headquarters
  5. 3.5 Global Biological Sample Cryopreservation Company Product Type and Application
  6. 3.6 Global Biological Sample Cryopreservation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biological Sample Cryopreservation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biological Sample Cryopreservation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biological Sample Cryopreservation Market by Type
  1. 4.1 Biological Sample Cryopreservation Type Introduction
  2. 4.1.1 Cryopreservation Equipment
  3. 4.1.2 Cryopreservation Media & Reagents
  4. 4.1.3 Cryopreservation Containers & Accessories
  5. 4.1.4 Cryopreservation Services
  6. 4.2 Global Biological Sample Cryopreservation Sales Value by Type
  7. 4.2.1 Global Biological Sample Cryopreservation Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biological Sample Cryopreservation Sales Value by Type (2021-2032)
  9. 4.2.3 Global Biological Sample Cryopreservation Sales Value Share by Type (2021-2032)
5 Biological Sample Cryopreservation Market by Application
  1. 5.1 Biological Sample Cryopreservation Application Introduction
  2. 5.1.1 Biobanking
  3. 5.1.2 Biomedical Research
  4. 5.1.3 Biopharmaceutical Manufacturing
  5. 5.1.4 Cell & Gene Therapy
  6. 5.1.5 Assisted Reproduction
  7. 5.1.6 Clinical Diagnostics
  8. 5.1.7 Animal Breeding
  9. 5.2 Global Biological Sample Cryopreservation Sales Value by Application
  10. 5.2.1 Global Biological Sample Cryopreservation Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Biological Sample Cryopreservation Sales Value by Application (2021-2032)
  12. 5.2.3 Global Biological Sample Cryopreservation Sales Value Share by Application (2021-2032)
6 Biological Sample Cryopreservation Regional Value Analysis
  1. 6.1 Global Biological Sample Cryopreservation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biological Sample Cryopreservation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biological Sample Cryopreservation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biological Sample Cryopreservation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biological Sample Cryopreservation Sales Value (2021-2032)
  7. 6.3.2 North America Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biological Sample Cryopreservation Sales Value (2021-2032)
  10. 6.4.2 Europe Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biological Sample Cryopreservation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biological Sample Cryopreservation Sales Value (2021-2032)
  16. 6.6.2 South America Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biological Sample Cryopreservation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biological Sample Cryopreservation Sales Value Share by Country, 2025 VS 2032
7 Biological Sample Cryopreservation Country-level Value Analysis
  1. 7.1 Global Biological Sample Cryopreservation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biological Sample Cryopreservation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biological Sample Cryopreservation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biological Sample Cryopreservation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biological Sample Cryopreservation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biological Sample Cryopreservation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biological Sample Cryopreservation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Biological Sample Cryopreservation Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Haier Biomedical
  8. 8.2.1 Haier Biomedical Company Information
  9. 8.2.2 Haier Biomedical Business Overview
  10. 8.2.3 Haier Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Haier Biomedical Biological Sample Cryopreservation Product Portfolio
  12. 8.2.5 Haier Biomedical Recent Developments
  13. 8.3 PHCbi
  14. 8.3.1 PHCbi Company Information
  15. 8.3.2 PHCbi Business Overview
  16. 8.3.3 PHCbi Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PHCbi Biological Sample Cryopreservation Product Portfolio
  18. 8.3.5 PHCbi Recent Developments
  19. 8.4 Repligen
  20. 8.4.1 Repligen Company Information
  21. 8.4.2 Repligen Business Overview
  22. 8.4.3 Repligen Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Repligen Biological Sample Cryopreservation Product Portfolio
  24. 8.4.5 Repligen Recent Developments
  25. 8.5 Cryoport
  26. 8.5.1 Cryoport Company Information
  27. 8.5.2 Cryoport Business Overview
  28. 8.5.3 Cryoport Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cryoport Biological Sample Cryopreservation Product Portfolio
  30. 8.5.5 Cryoport Recent Developments
  31. 8.6 Azenta Life Sciences
  32. 8.6.1 Azenta Life Sciences Company Information
  33. 8.6.2 Azenta Life Sciences Business Overview
  34. 8.6.3 Azenta Life Sciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Azenta Life Sciences Biological Sample Cryopreservation Product Portfolio
  36. 8.6.5 Azenta Life Sciences Recent Developments
  37. 8.7 Cytiva
  38. 8.7.1 Cytiva Company Information
  39. 8.7.2 Cytiva Business Overview
  40. 8.7.3 Cytiva Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cytiva Biological Sample Cryopreservation Product Portfolio
  42. 8.7.5 Cytiva Recent Developments
  43. 8.8 Sartorius
  44. 8.8.1 Sartorius Company Information
  45. 8.8.2 Sartorius Business Overview
  46. 8.8.3 Sartorius Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sartorius Biological Sample Cryopreservation Product Portfolio
  48. 8.8.5 Sartorius Recent Developments
  49. 8.9 FUJIFILM Biosciences
  50. 8.9.1 FUJIFILM Biosciences Company Information
  51. 8.9.2 FUJIFILM Biosciences Business Overview
  52. 8.9.3 FUJIFILM Biosciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 FUJIFILM Biosciences Biological Sample Cryopreservation Product Portfolio
  54. 8.9.5 FUJIFILM Biosciences Recent Developments
  55. 8.10 Lonza
  56. 8.10.1 Lonza Company Information
  57. 8.10.2 Lonza Business Overview
  58. 8.10.3 Lonza Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lonza Biological Sample Cryopreservation Product Portfolio
  60. 8.10.5 Lonza Recent Developments
  61. 8.11 Corning
  62. 8.11.1 Corning Company Information
  63. 8.11.2 Corning Business Overview
  64. 8.11.3 Corning Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Corning Biological Sample Cryopreservation Product Portfolio
  66. 8.11.5 Corning Recent Developments
  67. 8.12 Eppendorf
  68. 8.12.1 Eppendorf Company Information
  69. 8.12.2 Eppendorf Business Overview
  70. 8.12.3 Eppendorf Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eppendorf Biological Sample Cryopreservation Product Portfolio
  72. 8.12.5 Eppendorf Recent Developments
  73. 8.13 Greiner
  74. 8.13.1 Greiner Company Information
  75. 8.13.2 Greiner Business Overview
  76. 8.13.3 Greiner Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Greiner Biological Sample Cryopreservation Product Portfolio
  78. 8.13.5 Greiner Recent Developments
  79. 8.14 SARSTEDT
  80. 8.14.1 SARSTEDT Company Information
  81. 8.14.2 SARSTEDT Business Overview
  82. 8.14.3 SARSTEDT Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SARSTEDT Biological Sample Cryopreservation Product Portfolio
  84. 8.14.5 SARSTEDT Recent Developments
  85. 8.15 Terumo
  86. 8.15.1 Terumo Company Information
  87. 8.15.2 Terumo Business Overview
  88. 8.15.3 Terumo Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Terumo Biological Sample Cryopreservation Product Portfolio
  90. 8.15.5 Terumo Recent Developments
  91. 8.16 CooperSurgical
  92. 8.16.1 CooperSurgical Company Information
  93. 8.16.2 CooperSurgical Business Overview
  94. 8.16.3 CooperSurgical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CooperSurgical Biological Sample Cryopreservation Product Portfolio
  96. 8.16.5 CooperSurgical Recent Developments
  97. 8.17 Vitrolife
  98. 8.17.1 Vitrolife Company Information
  99. 8.17.2 Vitrolife Business Overview
  100. 8.17.3 Vitrolife Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Vitrolife Biological Sample Cryopreservation Product Portfolio
  102. 8.17.5 Vitrolife Recent Developments
  103. 8.18 Nexpring Health
  104. 8.18.1 Nexpring Health Company Information
  105. 8.18.2 Nexpring Health Business Overview
  106. 8.18.3 Nexpring Health Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Nexpring Health Biological Sample Cryopreservation Product Portfolio
  108. 8.18.5 Nexpring Health Recent Developments
  109. 8.19 Macopharma
  110. 8.19.1 Macopharma Company Information
  111. 8.19.2 Macopharma Business Overview
  112. 8.19.3 Macopharma Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Macopharma Biological Sample Cryopreservation Product Portfolio
  114. 8.19.5 Macopharma Recent Developments
  115. 8.20 Miltenyi Biotec
  116. 8.20.1 Miltenyi Biotec Company Information
  117. 8.20.2 Miltenyi Biotec Business Overview
  118. 8.20.3 Miltenyi Biotec Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Miltenyi Biotec Biological Sample Cryopreservation Product Portfolio
  120. 8.20.5 Miltenyi Biotec Recent Developments
  121. 8.21 STEMCELL Technologies
  122. 8.21.1 STEMCELL Technologies Company Information
  123. 8.21.2 STEMCELL Technologies Business Overview
  124. 8.21.3 STEMCELL Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  125. 8.21.4 STEMCELL Technologies Biological Sample Cryopreservation Product Portfolio
  126. 8.21.5 STEMCELL Technologies Recent Developments
  127. 8.22 Kitazato
  128. 8.22.1 Kitazato Company Information
  129. 8.22.2 Kitazato Business Overview
  130. 8.22.3 Kitazato Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Kitazato Biological Sample Cryopreservation Product Portfolio
  132. 8.22.5 Kitazato Recent Developments
  133. 8.23 Zhongke Meiling Cryogenics
  134. 8.23.1 Zhongke Meiling Cryogenics Company Information
  135. 8.23.2 Zhongke Meiling Cryogenics Business Overview
  136. 8.23.3 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Zhongke Meiling Cryogenics Biological Sample Cryopreservation Product Portfolio
  138. 8.23.5 Zhongke Meiling Cryogenics Recent Developments
  139. 8.24 AUCMA
  140. 8.24.1 AUCMA Company Information
  141. 8.24.2 AUCMA Business Overview
  142. 8.24.3 AUCMA Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  143. 8.24.4 AUCMA Biological Sample Cryopreservation Product Portfolio
  144. 8.24.5 AUCMA Recent Developments
  145. 8.25 BIOBASE
  146. 8.25.1 BIOBASE Company Information
  147. 8.25.2 BIOBASE Business Overview
  148. 8.25.3 BIOBASE Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  149. 8.25.4 BIOBASE Biological Sample Cryopreservation Product Portfolio
  150. 8.25.5 BIOBASE Recent Developments
  151. 8.26 Genepoint Technologies
  152. 8.26.1 Genepoint Technologies Company Information
  153. 8.26.2 Genepoint Technologies Business Overview
  154. 8.26.3 Genepoint Technologies Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Genepoint Technologies Biological Sample Cryopreservation Product Portfolio
  156. 8.26.5 Genepoint Technologies Recent Developments
  157. 8.27 Origincell Biological Cryo Equipment
  158. 8.27.1 Origincell Biological Cryo Equipment Company Information
  159. 8.27.2 Origincell Biological Cryo Equipment Business Overview
  160. 8.27.3 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Origincell Biological Cryo Equipment Biological Sample Cryopreservation Product Portfolio
  162. 8.27.5 Origincell Biological Cryo Equipment Recent Developments
  163. 8.28 Basecare Medical
  164. 8.28.1 Basecare Medical Company Information
  165. 8.28.2 Basecare Medical Business Overview
  166. 8.28.3 Basecare Medical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Basecare Medical Biological Sample Cryopreservation Product Portfolio
  168. 8.28.5 Basecare Medical Recent Developments
  169. 8.29 Hamilton Company
  170. 8.29.1 Hamilton Company Company Information
  171. 8.29.2 Hamilton Company Business Overview
  172. 8.29.3 Hamilton Company Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Hamilton Company Biological Sample Cryopreservation Product Portfolio
  174. 8.29.5 Hamilton Company Recent Developments
  175. 8.30 LiCONiC
  176. 8.30.1 LiCONiC Company Information
  177. 8.30.2 LiCONiC Business Overview
  178. 8.30.3 LiCONiC Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  179. 8.30.4 LiCONiC Biological Sample Cryopreservation Product Portfolio
  180. 8.30.5 LiCONiC Recent Developments
  181. 8.31 ASKION
  182. 8.31.1 ASKION Company Information
  183. 8.31.2 ASKION Business Overview
  184. 8.31.3 ASKION Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  185. 8.31.4 ASKION Biological Sample Cryopreservation Product Portfolio
  186. 8.31.5 ASKION Recent Developments
  187. 8.32 SPT Labtech
  188. 8.32.1 SPT Labtech Company Information
  189. 8.32.2 SPT Labtech Business Overview
  190. 8.32.3 SPT Labtech Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  191. 8.32.4 SPT Labtech Biological Sample Cryopreservation Product Portfolio
  192. 8.32.5 SPT Labtech Recent Developments
  193. 8.33 B Medical Systems
  194. 8.33.1 B Medical Systems Company Information
  195. 8.33.2 B Medical Systems Business Overview
  196. 8.33.3 B Medical Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  197. 8.33.4 B Medical Systems Biological Sample Cryopreservation Product Portfolio
  198. 8.33.5 B Medical Systems Recent Developments
  199. 8.34 Custom Biogenic Systems
  200. 8.34.1 Custom Biogenic Systems Company Information
  201. 8.34.2 Custom Biogenic Systems Business Overview
  202. 8.34.3 Custom Biogenic Systems Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  203. 8.34.4 Custom Biogenic Systems Biological Sample Cryopreservation Product Portfolio
  204. 8.34.5 Custom Biogenic Systems Recent Developments
  205. 8.35 IC Biomedical
  206. 8.35.1 IC Biomedical Company Information
  207. 8.35.2 IC Biomedical Business Overview
  208. 8.35.3 IC Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  209. 8.35.4 IC Biomedical Biological Sample Cryopreservation Product Portfolio
  210. 8.35.5 IC Biomedical Recent Developments
  211. 8.36 Cryo Bio System
  212. 8.36.1 Cryo Bio System Company Information
  213. 8.36.2 Cryo Bio System Business Overview
  214. 8.36.3 Cryo Bio System Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  215. 8.36.4 Cryo Bio System Biological Sample Cryopreservation Product Portfolio
  216. 8.36.5 Cryo Bio System Recent Developments
  217. 8.37 Stirling Ultracold
  218. 8.37.1 Stirling Ultracold Company Information
  219. 8.37.2 Stirling Ultracold Business Overview
  220. 8.37.3 Stirling Ultracold Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  221. 8.37.4 Stirling Ultracold Biological Sample Cryopreservation Product Portfolio
  222. 8.37.5 Stirling Ultracold Recent Developments
  223. 8.38 Helmer Scientific
  224. 8.38.1 Helmer Scientific Company Information
  225. 8.38.2 Helmer Scientific Business Overview
  226. 8.38.3 Helmer Scientific Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  227. 8.38.4 Helmer Scientific Biological Sample Cryopreservation Product Portfolio
  228. 8.38.5 Helmer Scientific Recent Developments
  229. 8.39 Micronic
  230. 8.39.1 Micronic Company Information
  231. 8.39.2 Micronic Business Overview
  232. 8.39.3 Micronic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  233. 8.39.4 Micronic Biological Sample Cryopreservation Product Portfolio
  234. 8.39.5 Micronic Recent Developments
  235. 8.40 OriGen Biomedical
  236. 8.40.1 OriGen Biomedical Company Information
  237. 8.40.2 OriGen Biomedical Business Overview
  238. 8.40.3 OriGen Biomedical Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  239. 8.40.4 OriGen Biomedical Biological Sample Cryopreservation Product Portfolio
  240. 8.40.5 OriGen Biomedical Recent Developments
  241. 8.41 BINDER
  242. 8.41.1 BINDER Company Information
  243. 8.41.2 BINDER Business Overview
  244. 8.41.3 BINDER Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  245. 8.41.4 BINDER Biological Sample Cryopreservation Product Portfolio
  246. 8.41.5 BINDER Recent Developments
  247. 8.42 Liebherr
  248. 8.42.1 Liebherr Company Information
  249. 8.42.2 Liebherr Business Overview
  250. 8.42.3 Liebherr Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  251. 8.42.4 Liebherr Biological Sample Cryopreservation Product Portfolio
  252. 8.42.5 Liebherr Recent Developments
  253. 8.43 Esco Lifesciences
  254. 8.43.1 Esco Lifesciences Company Information
  255. 8.43.2 Esco Lifesciences Business Overview
  256. 8.43.3 Esco Lifesciences Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  257. 8.43.4 Esco Lifesciences Biological Sample Cryopreservation Product Portfolio
  258. 8.43.5 Esco Lifesciences Recent Developments
  259. 8.44 Cryopal
  260. 8.44.1 Cryopal Company Information
  261. 8.44.2 Cryopal Business Overview
  262. 8.44.3 Cryopal Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  263. 8.44.4 Cryopal Biological Sample Cryopreservation Product Portfolio
  264. 8.44.5 Cryopal Recent Developments
  265. 8.45 Cryotherm
  266. 8.45.1 Cryotherm Company Information
  267. 8.45.2 Cryotherm Business Overview
  268. 8.45.3 Cryotherm Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  269. 8.45.4 Cryotherm Biological Sample Cryopreservation Product Portfolio
  270. 8.45.5 Cryotherm Recent Developments
  271. 8.46 Cryo Diffusion
  272. 8.46.1 Cryo Diffusion Company Information
  273. 8.46.2 Cryo Diffusion Business Overview
  274. 8.46.3 Cryo Diffusion Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  275. 8.46.4 Cryo Diffusion Biological Sample Cryopreservation Product Portfolio
  276. 8.46.5 Cryo Diffusion Recent Developments
  277. 8.47 Statebourne Cryogenics
  278. 8.47.1 Statebourne Cryogenics Company Information
  279. 8.47.2 Statebourne Cryogenics Business Overview
  280. 8.47.3 Statebourne Cryogenics Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  281. 8.47.4 Statebourne Cryogenics Biological Sample Cryopreservation Product Portfolio
  282. 8.47.5 Statebourne Cryogenics Recent Developments
  283. 8.48 Celltrio
  284. 8.48.1 Celltrio Company Information
  285. 8.48.2 Celltrio Business Overview
  286. 8.48.3 Celltrio Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  287. 8.48.4 Celltrio Biological Sample Cryopreservation Product Portfolio
  288. 8.48.5 Celltrio Recent Developments
  289. 8.49 ThermoGenesis
  290. 8.49.1 ThermoGenesis Company Information
  291. 8.49.2 ThermoGenesis Business Overview
  292. 8.49.3 ThermoGenesis Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  293. 8.49.4 ThermoGenesis Biological Sample Cryopreservation Product Portfolio
  294. 8.49.5 ThermoGenesis Recent Developments
  295. 8.50 Jiangsu SERLNG
  296. 8.50.1 Jiangsu SERLNG Company Information
  297. 8.50.2 Jiangsu SERLNG Business Overview
  298. 8.50.3 Jiangsu SERLNG Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  299. 8.50.4 Jiangsu SERLNG Biological Sample Cryopreservation Product Portfolio
  300. 8.50.5 Jiangsu SERLNG Recent Developments
  301. 8.51 SYLAB
  302. 8.51.1 SYLAB Company Information
  303. 8.51.2 SYLAB Business Overview
  304. 8.51.3 SYLAB Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  305. 8.51.4 SYLAB Biological Sample Cryopreservation Product Portfolio
  306. 8.51.5 SYLAB Recent Developments
  307. 8.52 Consarctic
  308. 8.52.1 Consarctic Company Information
  309. 8.52.2 Consarctic Business Overview
  310. 8.52.3 Consarctic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  311. 8.52.4 Consarctic Biological Sample Cryopreservation Product Portfolio
  312. 8.52.5 Consarctic Recent Developments
  313. 8.53 PromoCell
  314. 8.53.1 PromoCell Company Information
  315. 8.53.2 PromoCell Business Overview
  316. 8.53.3 PromoCell Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  317. 8.53.4 PromoCell Biological Sample Cryopreservation Product Portfolio
  318. 8.53.5 PromoCell Recent Developments
  319. 8.54 FertiPro
  320. 8.54.1 FertiPro Company Information
  321. 8.54.2 FertiPro Business Overview
  322. 8.54.3 FertiPro Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  323. 8.54.4 FertiPro Biological Sample Cryopreservation Product Portfolio
  324. 8.54.5 FertiPro Recent Developments
  325. 8.55 CryoLogic
  326. 8.55.1 CryoLogic Company Information
  327. 8.55.2 CryoLogic Business Overview
  328. 8.55.3 CryoLogic Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  329. 8.55.4 CryoLogic Biological Sample Cryopreservation Product Portfolio
  330. 8.55.5 CryoLogic Recent Developments
  331. 8.56 Cryofab
  332. 8.56.1 Cryofab Company Information
  333. 8.56.2 Cryofab Business Overview
  334. 8.56.3 Cryofab Biological Sample Cryopreservation Revenue and Gross Margin (2021-2026)
  335. 8.56.4 Cryofab Biological Sample Cryopreservation Product Portfolio
  336. 8.56.5 Cryofab Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.